vs
Idexx Laboratories（IDXX）与Ryman Hospitality Properties, Inc.（RHP）财务数据对比。点击上方公司名可切换其他公司
Idexx Laboratories的季度营收约是Ryman Hospitality Properties, Inc.的1.6倍（$1.1B vs $664.6M），Idexx Laboratories净利率更高（22.8% vs 10.4%，领先12.3%），Idexx Laboratories同比增速更快（14.3% vs 13.2%），过去两年Idexx Laboratories的营收复合增速更高（6.4% vs 4.1%）
IDEXX Laboratories是1983年成立的美国跨国企业，主营伴侣动物诊疗、畜禽养殖、水质检测、乳制品领域相关产品与服务的研发、生产及分销，总部位于缅因州韦斯特布鲁克，欧洲、中东及非洲地区分部设于荷兰霍夫多普。
莱曼酒店地产是一家主营酒店、度假村、娱乐及媒体业务的企业，得名于旗下位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司历史可追溯至曾为俄克拉荷马出版公司子公司时期，1983年收购WSM公司后奠定现代业务基础，同时将知名演出IP大奥普里等核心资产纳入麾下。
IDXX vs RHP — 直观对比
营收规模更大
IDXX
是对方的1.6倍
$664.6M
营收增速更快
IDXX
高出1.1%
13.2%
净利率更高
IDXX
高出12.3%
10.4%
两年增速更快
IDXX
近两年复合增速
4.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $664.6M |
| 净利润 | $248.2M | $69.4M |
| 毛利率 | 60.3% | — |
| 营业利润率 | 28.9% | 20.7% |
| 净利率 | 22.8% | 10.4% |
| 营收同比 | 14.3% | 13.2% |
| 净利润同比 | 14.8% | 10.1% |
| 每股收益（稀释后） | $3.09 | $1.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDXXRHP
| Q1 26 | — | $664.6M | ||
| Q4 25 | $1.1B | $737.8M | ||
| Q3 25 | $1.1B | $592.5M | ||
| Q2 25 | $1.1B | $659.5M | ||
| Q1 25 | $998.4M | $587.3M | ||
| Q4 24 | $954.3M | $647.6M | ||
| Q3 24 | $975.5M | $550.0M | ||
| Q2 24 | $1.0B | $613.3M |
净利润IDXXRHP
| Q1 26 | — | $69.4M | ||
| Q4 25 | $248.2M | $74.5M | ||
| Q3 25 | $274.6M | $34.9M | ||
| Q2 25 | $294.0M | $71.8M | ||
| Q1 25 | $242.7M | $63.0M | ||
| Q4 24 | $216.1M | $72.3M | ||
| Q3 24 | $232.8M | $59.0M | ||
| Q2 24 | $203.3M | $100.8M |
毛利率IDXXRHP
| Q1 26 | — | — | ||
| Q4 25 | 60.3% | 41.4% | ||
| Q3 25 | 61.8% | 40.9% | ||
| Q2 25 | 62.6% | 49.7% | ||
| Q1 25 | 62.4% | 44.4% | ||
| Q4 24 | 59.8% | 40.4% | ||
| Q3 24 | 61.1% | 43.1% | ||
| Q2 24 | 61.7% | 48.4% |
营业利润率IDXXRHP
| Q1 26 | — | 20.7% | ||
| Q4 25 | 28.9% | 19.4% | ||
| Q3 25 | 32.1% | 15.0% | ||
| Q2 25 | 33.6% | 21.1% | ||
| Q1 25 | 31.7% | 19.8% | ||
| Q4 24 | 27.4% | 18.6% | ||
| Q3 24 | 31.2% | 19.3% | ||
| Q2 24 | 26.3% | 27.4% |
净利率IDXXRHP
| Q1 26 | — | 10.4% | ||
| Q4 25 | 22.8% | 10.1% | ||
| Q3 25 | 24.8% | 5.9% | ||
| Q2 25 | 26.5% | 10.9% | ||
| Q1 25 | 24.3% | 10.7% | ||
| Q4 24 | 22.7% | 11.2% | ||
| Q3 24 | 23.9% | 10.7% | ||
| Q2 24 | 20.3% | 16.4% |
每股收益（稀释后）IDXXRHP
| Q1 26 | — | $1.03 | ||
| Q4 25 | $3.09 | $1.12 | ||
| Q3 25 | $3.40 | $0.53 | ||
| Q2 25 | $3.63 | $1.12 | ||
| Q1 25 | $2.96 | $1.00 | ||
| Q4 24 | $2.62 | $1.12 | ||
| Q3 24 | $2.80 | $0.94 | ||
| Q2 24 | $2.44 | $1.65 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.1M | — |
| 总债务越低越好 | $450.0M | — |
| 股东权益账面价值 | $1.6B | $770.8M |
| 总资产 | $3.4B | $6.2B |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
现金及短期投资IDXXRHP
| Q1 26 | — | — | ||
| Q4 25 | $180.1M | $471.4M | ||
| Q3 25 | $208.2M | $483.3M | ||
| Q2 25 | $164.6M | $420.6M | ||
| Q1 25 | $164.0M | $413.9M | ||
| Q4 24 | $288.3M | $477.7M | ||
| Q3 24 | $308.6M | $534.9M | ||
| Q2 24 | $401.6M | $498.4M |
总债务IDXXRHP
| Q1 26 | — | — | ||
| Q4 25 | $450.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $617.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益IDXXRHP
| Q1 26 | — | $770.8M | ||
| Q4 25 | $1.6B | $750.2M | ||
| Q3 25 | $1.6B | $758.5M | ||
| Q2 25 | $1.5B | $800.4M | ||
| Q1 25 | $1.4B | $531.5M | ||
| Q4 24 | $1.6B | $549.0M | ||
| Q3 24 | $1.6B | $551.9M | ||
| Q2 24 | $1.6B | $562.6M |
总资产IDXXRHP
| Q1 26 | — | $6.2B | ||
| Q4 25 | $3.4B | $6.2B | ||
| Q3 25 | $3.4B | $6.2B | ||
| Q2 25 | $3.3B | $6.1B | ||
| Q1 25 | $3.2B | $5.2B | ||
| Q4 24 | $3.3B | $5.2B | ||
| Q3 24 | $3.4B | $5.2B | ||
| Q2 24 | $3.4B | $5.1B |
负债/权益比IDXXRHP
| Q1 26 | — | — | ||
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.39× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $355.8M | — |
| 自由现金流经营现金流 - 资本支出 | $326.3M | — |
| 自由现金流率自由现金流/营收 | 29.9% | — |
| 资本支出强度资本支出/营收 | 2.7% | — |
| 现金转化率经营现金流/净利润 | 1.43× | — |
| 过去12个月自由现金流最近4个季度 | $1.1B | — |
8季度趋势，按日历期对齐
经营现金流IDXXRHP
| Q1 26 | — | — | ||
| Q4 25 | $355.8M | $164.7M | ||
| Q3 25 | $402.3M | $205.2M | ||
| Q2 25 | $185.7M | $122.5M | ||
| Q1 25 | $238.0M | $98.2M | ||
| Q4 24 | $262.0M | $166.6M | ||
| Q3 24 | $220.1M | $218.1M | ||
| Q2 24 | $248.3M | $184.3M |
自由现金流IDXXRHP
| Q1 26 | — | — | ||
| Q4 25 | $326.3M | $58.5M | ||
| Q3 25 | $371.2M | $135.4M | ||
| Q2 25 | $151.6M | $53.0M | ||
| Q1 25 | $207.9M | $-14.5M | ||
| Q4 24 | $232.8M | $76.0M | ||
| Q3 24 | $192.0M | $85.7M | ||
| Q2 24 | $215.0M | $78.8M |
自由现金流率IDXXRHP
| Q1 26 | — | — | ||
| Q4 25 | 29.9% | 7.9% | ||
| Q3 25 | 33.6% | 22.9% | ||
| Q2 25 | 13.7% | 8.0% | ||
| Q1 25 | 20.8% | -2.5% | ||
| Q4 24 | 24.4% | 11.7% | ||
| Q3 24 | 19.7% | 15.6% | ||
| Q2 24 | 21.4% | 12.9% |
资本支出强度IDXXRHP
| Q1 26 | — | — | ||
| Q4 25 | 2.7% | 14.4% | ||
| Q3 25 | 2.8% | 11.8% | ||
| Q2 25 | 3.1% | 10.5% | ||
| Q1 25 | 3.0% | 19.2% | ||
| Q4 24 | 3.1% | 14.0% | ||
| Q3 24 | 2.9% | 24.1% | ||
| Q2 24 | 3.3% | 17.2% |
现金转化率IDXXRHP
| Q1 26 | — | — | ||
| Q4 25 | 1.43× | 2.21× | ||
| Q3 25 | 1.47× | 5.88× | ||
| Q2 25 | 0.63× | 1.71× | ||
| Q1 25 | 0.98× | 1.56× | ||
| Q4 24 | 1.21× | 2.30× | ||
| Q3 24 | 0.95× | 3.70× | ||
| Q2 24 | 1.22× | 1.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
RHP
| Food and beverage | $289.3M | 44% |
| Rooms | $223.8M | 34% |
| Entertainment | $79.2M | 12% |
| Other | $72.3M | 11% |
